These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15065491)

  • 21. Diagnosis and management of heart failure in the long-term care setting.
    Gaulden L
    Director; 2003; 11(4):177-81. PubMed ID: 14608703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of heart failure and preserved systolic function].
    Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
    Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker.
    Berry C; Murphy NF; De Vito G; Galloway S; Seed A; Fisher C; Sattar N; Vallance P; Hillis WS; McMurray J
    Eur J Heart Fail; 2007 Apr; 9(4):429-34. PubMed ID: 17126073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 25. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
    Ahmad T; Patel CB; Milano CA; Rogers JG
    Circulation; 2012 Jun; 125(23):2948-55. PubMed ID: 22689932
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of chronic heart failure: an old disease with a new face.
    Prendergast HM; Bunney EB
    Emerg Med Australas; 2005 Apr; 17(2):143-51. PubMed ID: 15796729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we inhibit angiotensin-converting enzymes in acute heart failure?
    Lamond NW; Howlett JG
    Heart Fail Monit; 2007; 5(3):70-6. PubMed ID: 17487295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New and emerging drug therapies for the management of acute heart failure.
    Krum H; Liew D
    Intern Med J; 2003 Nov; 33(11):515-20. PubMed ID: 14656255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
    MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
    [No Abstract]   [Full Text] [Related]  

  • 31. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 32. Brain natriuretic peptide-guided management of chronic heart failure: first do no harm.
    Richards AM
    Eur J Heart Fail; 2013 Aug; 15(8):832-4. PubMed ID: 23821462
    [No Abstract]   [Full Text] [Related]  

  • 33. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

  • 34. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
    [No Abstract]   [Full Text] [Related]  

  • 37. Overview of emerging pharmacologic agents for acute heart failure syndromes.
    De Luca L; Mebazaa A; Filippatos G; Parissis JT; Böhm M; Voors AA; Nieminen M; Zannad F; Rhodes A; El-Banayosy A; Dickstein K; Gheorghiade M
    Eur J Heart Fail; 2008 Feb; 10(2):201-13. PubMed ID: 18279775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma brain natriuretic peptide-guided therapy not yet justified.
    Hoppe UC
    J Am Coll Cardiol; 2007 Nov; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    Weir RA; McMurray JJ; Puu M; Solomon SD; Olofsson B; Granger CB; Yusuf S; Michelson EL; Swedberg K; Pfeffer MA;
    Eur J Heart Fail; 2008 Feb; 10(2):157-63. PubMed ID: 18242128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiac insufficiency: therapeutic aspects in the elderly person].
    Perrenoud JJ
    Praxis (Bern 1994); 1996 Feb; 85(6):164-7. PubMed ID: 8701179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.